📣 Introducing Tracenable Pro: Unlock Unlimited Data Exports & Disclosures Access.
Astellas Pharma Inc
Astellas Pharma's GHG Emissions Data Preview
In 2024, Astellas Pharma completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources), Scope 2 (indirect emissions from purchased energy) and Scope 3 (indirect emissions across the value chain).
Astellas Pharma has also provided a category-level breakdown for 10 out of 15 Scope 3 emissions categories, offering greater transparency into its value chain emissions.
| Metric (tCO2e) | 2024 | 2023 | 2022 | 2021 - 2017 |
|---|---|---|---|---|
Total Scope 1 | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | 0000000 |
Total Scope 2 | ||||
Market-Based | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | 0000000 |
Location-Based | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 3 | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | 0000000 |
Total Scope 1 Revenue Intensity (tCO2e/$M) | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | 0000000 |
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
aVerified Sources Behind Astellas Pharma’s Greenhouse Gas (GHG) Emissions Data
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Astellas Pharma’s data sources below and access millions more through our Disclosure Search.
Insights into Astellas Pharma's Operational Emissions
In 2024, the total operational greenhouse gas (GHG) emissions ofAstellas Pharma amounted to107,833metric tons of CO2 equivalent.This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2).a
Compared to 2023, the total operational greenhouse gas (GHG) emissions of Astellas Pharmadecreased by 11.79%, showing that the company has made progress in taking action to reduce the climate impact of its operations.a
Astellas Pharma's Scope 1 Emissions Over Time
- Total Scope 1
- Year-over-Year Change
What are Astellas Pharma's Scope 1 emissions?
In 2024, the total Scope 1 emissions of Astellas Pharma were 52,212 metric tons of COâ‚‚ equivalent (tCOâ‚‚e).a
Has Astellas Pharma reduced its Scope 1 emissions over time?
Since 2019, Astellas Pharma's Scope 1 emissions have decreased by 26.36%, reflecting a declining long-term trend in Scope 1 emissions over time.ab
Compared to the previous year(2023), Astellas Pharma's Scope 1 emissions decreased by 11.81%, highlighting the company's efforts to lower direct emissions from assets it owns or controls.a
What are Astellas Pharma's Scope 2 emissions?
In 2024, Astellas Pharma reported Scope 2 greenhouse gas (GHG) emissions of 55,621 tCOâ‚‚e using the market-based method.a
Has Astellas Pharma reduced its Scope 2 emissions over time?
Since 2019, Astellas Pharma's Scope 2 greenhouse gas (GHG) emissions (Market-Based)have decreased by 41.6%, reflecting a declining long-term trend in Scope 2 emissions over time.ab
Compared to the previous year(2023), Astellas Pharma's Scope 2 emissions(Market-Based) fell by 11.78% in 2024, showing that the company has made progress in taking action to reduce the climate impact of its energy consumption.a
What methodology does Astellas Pharma use for Scope 2 reporting?
In 2024, Astellas Pharma reported its Scope 2 emissions using the market-based method.a
Astellas Pharma's Scope 2 Emissions Over Time
- Total Scope 2 Market-Based
Insights into Astellas Pharma's Value Chain Emissions
In 2024, Astellas Pharma reported 1,276,323 metric tons of COâ‚‚ equivalent (tCOâ‚‚e) of Scope 3 greenhouse gas (GHG) emissions, representing indirect emissions across its upstream and downstream value chain.a
The 2024 disclosure of Astellas Pharma includes a breakdown across 10of the 15 Scope 3 categories defined by the GHG Protocol,matching the level of disclosure in 2023, demonstrating consistent Scope 3 emissions reporting coverage year over year.a
Astellas Pharma's Scope 3 Emissions Over Time
- Total Scope 3
- Year-over-Year Change
What are Astellas Pharma's Scope 3 emissions?
In 2024, Astellas Pharma reported total Scope 3 emissions of 1,276,323 metric tons of COâ‚‚ equivalent (tCOâ‚‚e).a
Approximately 99.72%of these emissions originated from upstream activities such as purchased goods and capital goods, while 0.28%came from downstream activities like product use, distribution, and end-of-life treatment.a
Has Astellas Pharma reduced its Scope 3 emissions over time?
Since 2019, Astellas Pharma's Scope 3 emissionshave increased by 455.04%, reflecting a rising long-term trend in Scope 3 emissions over time.ab
Compared to the previous year (2023), Astellas Pharma's Scope 3 emissions increased by 13.82%, suggesting that the company faced challenges in reducing emissions across its value chain.a
What categories of Scope 3 emissions does Astellas Pharma disclose?
In 2024, Astellas Pharma reported emissions for 10 out of the 15 Scope 3 categories defined by the GHG Protocol.a
This reflects a high level of granularity and transparency in the company's emissions reporting.
What are the main sources of Astellas Pharma's Scope 3 emissions?
In 2024, the largest contributors to Astellas Pharma's Scope 3 emissions were:a
- Purchased Goods and Services (Cat. 1): 1,082,536 tCOâ‚‚e(84.82%)
- Capital Goods (Cat. 2): 90,582 tCOâ‚‚e(7.1%)
- Business Travel (Cat. 6): 34,056 tCOâ‚‚e(2.67%)
Astellas Pharma's Scope 3 Emissions by Categories
Insights into Astellas Pharma’s GHG Emissions Intensity Compared to Industry Peers
In 2024, Astellas Pharma reported Scope 1 greenhouse gas (GHG) emissions of 52,212 tCOâ‚‚e and total revenues of USD 10,589 millions. This translates into an emissions intensity of 4.93 tCOâ‚‚e per millions USD.a
Astellas Pharma's Scope 1 Emissions Intensity Compared to Peers
How does Astellas Pharma's GHG emissions intensity compare to its peers?
In 2024, Astellas Pharma reported a Scope 1 emissions intensity of 4.93 tCOâ‚‚e per millions USD. Compared to the peer group median of 3.63, this places the company above its industry benchmark, indicating it is less carbon-efficient than most competitors.a
Where does Astellas Pharma rank on GHG emissions intensity within its industry?
In 2024, Astellas Pharma ranked 14 out of 23 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCOâ‚‚e per millions USD).a
Astellas Pharma is therefore positioned in the mid-range of its industry, neither a clear leader nor a laggard in carbon efficiency.a
Insights into Astellas Pharma's Total Carbon Footprint
In 2024, Astellas Pharma reported a total carbon footprint of 1,384,156 metric tons of COâ‚‚ equivalent (tCOâ‚‚e) across Scope 1, Scope 2, and Scope 3 emissions. This represents a 11.3% increase compared to 2023, suggesting a rise in emissions across its operations or value chain.a
The largest contributor to Astellas Pharma's total carbon footprint was Scope 3 emissions, accounting for 92.21% of the company's total carbon footprint, followed by Scope 2 emissions at 4.02%.a